Cell Point (India) (NSE:CELLPOINT) YoY EBITDA Growth: 19.25% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CELLPOINT Cell Point (India) Ltd NSE:CELLPOINT
68 GF Score
Price ₹16.30
GF Value ₹35.26
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Cell Point (India) YoY EBITDA Growth?

Cell Point (India) NSE:CELLPOINT 68 YoY EBITDA Growth is 19.25% as of Mar. 2026. GuruFocus rates NSE:CELLPOINT with a GF Score™ of 68/100 and a GF Value™ of ₹35.26 (Significantly Undervalued). The stock has 6 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cell Point (India)'s YoY EBITDA Growth for the quarter that ended in Mar. 2026 was 19.25%.

Cell Point (India)'s EBITDA per Share for the six months ended in Mar. 2026 was ₹3.37.

Cell Point (India) YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Cell Point (India)'s YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Point (India) YoY EBITDA Growth Chart

Cell Point (India) Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
YoY EBITDA Growth
Get a 7-Day Free Trial 42.49 78.35 -41.40 7.56 -3.50

Cell Point (India) Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -55.12 -15.69 46.12 -24.18 19.25
NSE:CELLPOINT
68GF Score
Cell Point (India) Ltd NSE:CELLPOINT
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cell Point (India) YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cell Point (India)'s YoY EBITDA Growth for the fiscal year that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (A: Mar. 2026 )
=(EBITDA per Share (A: Mar. 2026 )-EBITDA per Share (A: Mar. 2025 ))/ | EBITDA per Share (A: Mar. 2025 ) |
=(5.792-6.002)/ | 6.002 |
=-3.50 %

Cell Point (India)'s YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(3.37-2.826)/ | 2.826 |
=19.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 19.25% mean?
Cell Point (India) (NSE:CELLPOINT) has a YoY EBITDA Growth of 19.25% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Cell Point (India) and its competitors.
Is Cell Point (India)'s YoY EBITDA Growth too high?
Cell Point (India)'s current YoY EBITDA Growth is 19.25%. Overall, Cell Point (India) has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s YoY EBITDA Growth compare to CASY and WSM?
Cell Point (India)'s YoY EBITDA Growth of 19.25% can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Retail - Cyclical company?
A good YoY EBITDA Growth depends on the Retail - Cyclical industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Cell Point (India) and its competitors. Cell Point (India)'s current YoY EBITDA Growth is 19.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹35.26, compared to a current price of ₹16.30 — trading 53.8% below its estimated fair value. The current YoY EBITDA Growth is 19.25%. Cell Point (India)'s overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current YoY EBITDA Growth is 19.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued. The current stock price of ₹16.30 is trading 53.8% below its estimated GF Value™ of ₹35.26. GuruFocus considers Cell Point (India) to be Significantly Undervalued.

Key valuation signals for NSE:CELLPOINT:

  • YoY EBITDA Growth: 19.25%
  • GF Value™: ₹35.26 vs. price of ₹16.30 (53.8% below fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cell Point (India) Business Description

Address Lalitha Colony, Door No. 30-15-134, Dabagardens, Visakhapatnam, AP, IND, 530020
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
68GF Score

Get the complete analysis for NSE:CELLPOINT

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹16.30
Price
₹35.26
GF Value